Another renal AID, i.e., membranous nephropathy (MN), is characterized by the presence of autoantibodies targeting phospholipase A2 receptor 1 (PLA2R1) and thrombospondin type-1 domain-containing protein 7A (THSD7A) [48]. This evidence concerns the gene PLA2R1 and membranous glomerulonephritis.